Daily Archives: June 4, 2019

Vricon and Cesium partner to bring users streaming 3D geodata

Vricon and Cesium roll out free trials of 3D data at GEOINT 2019 Symposium

McLean, Virginia, June 04, 2019 (GLOBE NEWSWIRE) — Vricon, a producer of geospatial 3D solutions, and Cesium—a complete platform for building time-dynamic, 3D geospatial applications—are disrupting the geospatial industry by providing accurate 3D geodata in the cloud and making it accessible for free until 24 June.

Announced at this year’s GEOINT 2019 Symposium in San Antonio, Texas, Vricon and Cesium are providing 3D digital surface models through Cesium ion, starting with highly detailed datasets for six cities.

Vricon and Cesium are making 3D Tiles available for a three-week trial that ends on 24 June.   Users can access these data sets by signing up for an ion account and navigating to the Asset Depot. For users new to Cesium, the Getting Started guide is a great place to begin.

Working with 3D data in Cesium ion enables users to see the world as it really exists, explain what they’re seeing more clearly, and help better convey their findings. During the free trial, it’s easy for developers and geospatial data users to login into or sign up for a Cesium ion account and start streaming Vricon 3D data to applications on any device.

“Because Vricon 3D data is now available through Cesium ion, individual users can experience the full power of 3D imagery,” said Magnus Brege, Vricon CEO. “Cesium ion is enabling us to provide access to a whole new set of users.”

The 3D Tiles free trial includes Cairo, Egypt; Caracas, Venezuela; Damascus, Syria; Tehran, Iran; Honolulu, Hawaii; and San Francisco, California.

“This free trial marks the beginning of a larger partnership with Vricon where we’ll provide access to more of their 3D photogrammetry data in Cesium,” said Patrick Cozzi, creator of Cesium. “We want more people to try applying 3D data to their mission, fuse it with other data, experience it through mobile devices—and see how this can help the important work they do.”

Vricon and Cesium invite GEOINT 2019 Symposium participants to visit their booths to view demonstrations of 3D analytics using Vricon data and Cesium ion.  Vricon is located in booth 701, and Cesium is located in booth 727.

About Vricon 

Vricon serves the global professional geospatial market with world-leading 3D geodata and 3D visualization solutions. Vricon is headquartered in McLean, Virginia. For further information, visit http://www.vricon.com.

About Cesium 

Cesium enables developers and data owners to build time-dynamic 3D geospatial applications using the best technology in the geospatial and computer graphics industries. With Cesium you can simultaneously visualize a range of data types, overlay time dynamic objects, conduct geospatial analysis on it all, and share your 3D maps online, across devices, and in the field. Cesium helps you unlock the potential of 3D geospatial data. https://cesium.com


Craig Brower

Bonnie Bogle

World’s top miners keep performing but investors unimpressed

  • Revenue up 8% to $683 billion
  • EBITDA up 4% to $165 billion
  • Record dividend paid to shareholders of $43 billion, up 13%
  • Market capitalisation of the Top 40 down 18% to $757 billion, 31 Dec 2018 with partial recovery to $849 bn at 30 Apr 2019

LONDON, June 04, 2019 (GLOBE NEWSWIRE) — The world’s 40 largest mining companies continued to consolidate their stellar performance of the past several years by delivering steady growth in 2018, according to PwC’s Mine 2019 report released today.

As a group, the Top 40 increased revenue by 8%, buoyed by higher commodity price rises, and lifted production by 2%. They also boosted cash flows, paid down debt and provided a record dividend to shareholders of $43 billion.  Forecasts indicate continued steady performance in 2019. Revenue should remain stable, with weaker prices for coal and copper offsetting marginally higher production and higher average prices for iron ore.

Yet investors seemed unimpressed by the Top 40’s result, judging by market valuations, which fell 18% over 2018. While total market capitalization rose in the first term of this year, it remains 8% down compared to the end of 2017.  Over the past 15 years, total shareholders’ return in mining has lagged that of the market as a whole as well as comparable industries such as oil and gas.

PwC’s Global Mining and Metals leader, Jock O’Callaghan, said: “One thing is clear – mining requires more than good financial performance to continue to create and realise value in a sustainable manner.

“We believe that the market has reservations about the mining industry’s ability to respond to the risks and uncertainties of a changing world.

“With strong balance sheets and cash flows, now is the time for the Top 40 to address the issues weighing down market values: climate change, shifting consumer sentiment, and technology adoption.

“Miners need to move swiftly to restore faith in ‘brand mining. As an industry, this means transforming their reputation as efficient ‘converters of dirt’ posing omnipresent environmental risk to prominent builders of both economic and societal capital. Prioritising greener and consumer-centric strategies, enabled by technology, will help earn the trust of stakeholders and enable miners to create sustainable value into the future.”

Balance sheets remain strong; capital expenditure up but slow

In 2018 the Top 40 paid down $15.5 billion in net borrowings, resulting in the gearing position dropping below the 10-year average. All liquidity and solvency ratios improved during the year, leaving the world’s largest miners with strong balance sheets and cash flows.

In line with expectations, capital expenditures started to rise again, albeit from historically low levels.  The 13% increase over the previous year to $57 billion suggests that miners are continuing to proceed cautiously; approximately half (48%) of the capital expenditure in 2018 was for ongoing projects.

Copper and gold dominated spending in 2018, attracting $30 billion worth of investment. Capital expenditure on coal was consistent, year on year, and it is expected that miners will maintain current production levels while the coal price remains high.

Shareholders, government and other stakeholders rewarded

An 11% lift in operating cash flows has allowed the Top 40 to increase shareholder distributions in 2018 to a record $43 billion. Dividend yield for the year was 5.5%. There was a notable jump in share buybacks to $15 billion, up from $4 billion in 2017. Rio Tinto and BHP accounted for 70% of the total activity returning proceeds of non-core disposals to shareholders.

“While their shareholders see buybacks as welcome news in the short term, miners need to ask whether this has come at a cost given the challenges of attracting long-term capital.” said Mr O’Callaghan.  “Equity raisings during the year remained at a paltry $3bn, lower than the preceding two years.”

In 2018 the share of value distributed to governments in the form of direct taxes and royalties increased from 19% to 21%. Employees received 22% of the total value distribution from the Top 40.

M&A activity picks up

After several years of sluggish activity, M&A picked up significantly in 2018. The value of announced transactions rose 137% to $30 billion, driven by a flurry of activity in the gold sector, the on-going push by miners to optimise their portfolios, and momentum to acquire energy metals projects.

“The renewed appetite for large transactions looks set to continue this year, with announced deal value to 30 April already exceeding the whole of 2017,” said Mr O’Callaghan. “Post merger disposal of non-core assets in revised portfolios will support more deals activity in the near term.”

Gold sector consolidating

The gold sector is experiencing a renewed round of consolidation, driven by a shrinking pipeline of projects, fewer new high-grade discoveries and a lack of funding for junior developments. Gold deals increased from 8% of total Top 40 deal value in 2017 to 25% in 2018, and this year are tracking at close to 95% of deals as at the end of April.

“In the current market, gold mining companies need to be rigorous and disciplined with prospective deals. Investors are still reeling from the spate of overpriced deals between 2005 to 2012, the value of which has now been lost,” Mr O’Callaghan said.

Notes to editors:

PwC’s Mine 2019 analysis is based on the major top 40 global mining companies by market capitalization. The results aggregated in this report have been sourced from the latest publicly available information, primarily annual reports and financial reports available to shareholders. The full report can be accessed via the following link: www.pwc.com/mine

About PwC

At PwC, our purpose is to build trust in society and solve important problems. We’re a network of firms in 157 countries with more than 223,000 people who are committed to delivering quality in assurance, advisory and tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com.

PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.

© 2019 PwC. All rights reserved

Contact David Bowden
Global Communications Manager | PwC
m: +44 (0)7483365049
e: david.bowden@pwc.com


Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease based on Transcranial Photobiomodulation.

Toronto, Canada, June 04, 2019 (GLOBE NEWSWIRE) –Vielight Inc. of Toronto, a leader in brain photobiomodulation (PBM) technology, announces that the primary site for its pivotal clinical trial, St. Michael’s Hospital, in Toronto, has been activated. The trial will be a randomized, placebo-controlled study involving 228 subjects with moderate to severe cognitive impairment due to Alzheimer’s Disease.

This pivotal trial will be conducted across North America. St. Michael’s Hospital is the first among the eight sites that will carry out the study. The protocol of the study has been reviewed by the U.S. Food and Drug Administration (FDA) and Health Canada.

The device in investigation, called the “Vielight Neuro RX Gamma”, is based on Vielight’s proprietary PBM technology which directs near infrared light, pulsing at the gamma rate of 40 Hz, to selected regions of the brain. The procedure is non-invasive, and the device has been designed to be suitable for home-use. Subject to regulatory clearance, the device will be indicated for Alzheimer patients with moderate to severe impairment, the group that demands the most care and has the largest economic burden.

This clinical trial is timely against the backdrop of many unsuccessful attempts by pharmaceutical and device companies to demonstrate acceptable efficacy and safety to address the disease. Currently, no other modality is in a clinical trial that is expected to demonstrate clinical outcomes within the time anticipated for the Vielight study to be completed.

Recently published studies have shed more light on the potential of the Neuro RX Gamma to modify the pathology of Alzheimer’s Disease. These studies presented findings in clinical assessments and functional magnetic resonance imaging (fMRI), warranting the move forward with the large pivotal clinical trial.

Recruitment for the study will begin shortly. The trial will be independently managed by the Applied Health Research Centre (AHRC), a methodology center affiliated with St. Michael’s Hospital. Further information and contact details for participation enquiries can be found at https://clinicaltrials.gov/ct2/show/NCT03484143.

Principal Investigator at St. Michael’s Hospital, Dr. Corinne Fischer, M.D., said, “In spite of substantial efforts to establish effective treatments for Alzheimer’s disease, progress has been, unfortunately, limited and a cure does not yet exist. Although not conventional as an Alzheimer’s disease solution, we look forward to investigating the potential of Vielight’s technology in the treatment of this difficult disease based on promising early evidence.”

Margaret A. Naeser, Ph.D., Research Professor of Neurology, Boston University School of Medicinesaid: “My research studies into the use of PBM in aphasia, post-traumatic stress disorder (PTSD), traumatic brain injury, and dementia have shown me that we are seeing just the tip of the iceberg of healing potential for this technology.”

Michael Hamblin Ph.D., Retired Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, and Associate Professor of Dermatology at Harvard Medical School, said, “For more than 50 years, researchers have been demonstrating the potential of PBM to treat many medical conditions. However, large controlled clinical trials have been elusive. Vielight has been the first to demonstrate successful clinical outcomes for dementia in small early investigations, and we look forward to the findings of this pivotal trial.”

Lew Lim, Ph.D., Founder and CEO of Vielight, expressed, “A very complex disease like Alzheimer’s poses a big challenge to any researcher, and even more so for a small team like ours. Despite the solid science and strong early evidence, few were ready to ride with us. I am grateful to the courageous parties who have helped us to get to this point of a major clinical trial. I hope that we will all be a part of something special and important in the end.”

About Vielight Inc.Vielight Inc. is a recognized leader in the application of photobiomodulation (PBM) for supporting mental and physical well-being. Much of Vielight’s work has been focused on research of the effects of PBM on the brain, and on translation of PBM technology into practical uses. For more info visit company’s website: https://vielight.com.


Gennady Lemud
Vielight Inc.

Cocoon Medical Appoints Miguel Pardos as Chief Executive Officer

Barcelona, Spain, May. 27, 2019 – Cocoon Medical (“Cocoon”), a leading developer and provider of energy-based aesthetic systems for practitioners worldwide, today announced the appointment of Miguel Pardos as its Chief Executive Officer (“CEO”), effective immediately.

Immediately prior to joining Cocoon, Mr. Pardos served as the Vice President Aesthetic APAC at Lumenis based in Hong Kong.  Prior to Lumenis, Mr. Pardos was the Executive Vice President International of Cutera Inc. from July 2014 until February 2018.  From 2009-2014, he was the Vice President Asia Pacific at Syneron Candela. At Syneron Candela, Mr. Pardos implemented commercial strategies for direct and distribution channel while integrating Candela into Syneron product portfolio. Prior to Syneron Candela Mr. Pardos held a variety of global management positions of increasing responsibility within GE Healthcare from 1999-2007, during his time at GE Healthcare Mr Pardos has held management positions in Spain, Germany, Australia and Singapore.

“We’re delighted to welcome Miguel to Cocoon, and are pleased to have been able to attract a seasoned aesthetic medical device industry executive of his caliber to lead Cocoon into its next phase of growth and international expansion,” said José Antonio Sánchez, Chairman and Founder of Cocoon Group. “ Mr. Pardos brings to Cocoon 20 years of executive leadership where 10 years were of direct experience in the Aesthetic industry with an strong international background, which I believe will contribute greatly to Cocoon’s new phase of growth and development”.

Mr. Pardos said, “I am honored to be joining Cocoon at this very important moment of growth and international expansion with a healthy product pipeline. Cocoon is a successful and innovative company well positioned to expand its footprint internationally by delivering the best products in the market under the brands Cooltech and Primelase in the categories of body shaping and laser hair removal respectively.  As part of the team I look forward to leading the organization to gain global market share through commercial execution and international expansion.”

Mr. Pardos holds a BS Engineering by UPC Barcelona and Master Engineering by University Europea Madrid. Mr. Pardos also holds an International EMBA by Instituto de Empresa (Ie).

About Cocoon Medical

Cocoon Medical is an international company headquartered in Barcelona. The company’s aim is to offer the highest technology and innovation at the aesthetic medicine field, developing medical and aesthetic equipment in order to satisfy the needs of the most demanding customers.
The continuous effort of each employee of cocoon medical has managed to consolidate its global positioning. Cocoon has developed a wide international penetration supported by more than 66 renowned distributors, in which Cocoon relies to meet the specific needs of each market  offering the most appropriate customized solutions to give the best service to customers.

Cocoon Medical  is characterized by its important and continuous investment in the development of superior innovations and quality by its own R & D department and factories,  the highest quality certifications, and the best service in the sector.



  • Biopharmaceutical veteran Edwina Baskin-Bey, M.D., joins Nanobiotix as its new Chief Medical Officer (CMO)
  • Dr. Baskin-Bey will leverage her expertise in medical strategy and late-stage clinical development to help accelerate the company’s strategic objectives
  • Dr. Baskin-Bey succeeds Elsa Borghi, M.D., who will remain focused on the early development of innovative products at Nanobiotix

“Dr. Baskin-Bey has built an impressive career and she is joining us at a critical time. As we advance development of NBTXR3 in multiple solid tumor indications and in combination with checkpoint inhibitors, Dr. Baskin-Bey’s breadth and depth of experience align perfectly with our strategic leadership needs. To date, Dr. Borghi has been instrumental in bringing our lead product to European market approval. I am excited that she will continue to create and develop new innovative approaches for Nanobiotix.” – Laurent Levy, CEO of Nanobiotix

“It is an honor and a privilege to join Nanobiotix. I am thrilled by the opportunity to lead a dedicated team that operates on the cutting edge of nanophysics to develop unique treatment solutions and improve patient outcomes. My experience in global oncology product development, surgery and radiation should serve to help us grow and to accelerate our global clinical programs.” – Dr. Edwina Baskin-Bey, CMO of Nanobiotix

Paris, France and Cambridge, Massachusetts, USA, June 4, 2019 – NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced it has appointed Edwina Baskin-Bey, M.D. as its new CMO.

Dr. Baskin-Bey brings over 18 years of oncology clinical development and basic science experience in academia and industry, most recently serving as CMO of North Carolina-based oncology start-up, Innocrin Pharmaceuticals. As a member of the Executive Team at Innocrin, Dr. Baskin-Bey led development and implementation of the overall clinical and corporate strategy from phase I to phase III. She was responsible for the Medical, Regulatory, Pharmacovigilance, Clinical Operations, Biostatistics, and Data Management functions.

Dr. Baskin-Bey joined Innocrin from Janssen Oncology of Johnson & Johnson, where she was charged with leading both early- and late-stage oncology global development programs for in-licensed products from Aragon and Tesaro, apalutamide and niraparib. Previously, she worked for more than six years at Astellas Pharma. At Astellas, BV, Netherlands Headquarters, Dr. Baskin-Bey, was responsible for several early-stage oncology programs, most notably, she co-led with the alliance partner, Medivation, the global development strategy for the in-licensed product enzalutamide, leading to FDA approval, EMA approval, and label expansions. Also while at Astellas, she served at the UK Headquarters as head of European Medical Affairs, where she was responsible for the launch of enzalutamide in Europe.

Dr. Baskin-Bey currently serves as an independent board member for Catalyst Clinical Research, LLC, in North Carolina. Dr. Baskin-Bey obtained her bachelor’s degree from Hunter College in New York, and earned her medical degree at Mount Sinai/New York University (NYU) School of Medicine. She trained in general surgery and oncology for seven years at The Mayo Clinic in Rochester, MN, and in basic science research principles at the National Institute of Health (NIH).

Dr. Baskin-Bey succeeds accomplished Nanobiotix CMO, Elsa Borghi, M.D. Dr. Borghi will remain with the company in a key leadership role focused on early development and innovation.

About NANOBIOTIX: www.nanobiotix.com

Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell.

The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges.

Nanobiotix’s first-in-class, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotix’s Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.

Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP). The Company’s headquarters are in Paris, France, with a U.S. affiliate in Cambridge, MA, and European affiliates in Spain and Germany.


Communications Department
+33 (0)1 40 26 07 55
+1 (617) 852-4835

Investor Relations Department
+33 (0)1 79 97 29 99
+1 (646) 241-4400

Media relations
France – Springbok Consultants
Marina Rosoff
+33 (0)6 71 58 00 34
United States – RooneyPartners
Marion Janic
+1 (212) 223-4017



This press release contains certain forward-looking statements concerning Nanobiotix and its business, including its prospects and product candidate development. Such forward-looking statements are based on assumptions that Nanobiotix considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the reference document of Nanobiotix registered with the French Financial Markets Authority (Autorité des Marchés Financiers) under number R.19-018 on April 30, 2019 (a copy of which is available on www.nanobiotix.com) and to the development of economic conditions, financial markets and the markets in which Nanobiotix operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Nanobiotix or not currently considered material by Nanobiotix. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Nanobiotix to be materially different from such forward-looking statements.


COAST Autonomous ปรับปรุงความปลอดภัยของยานพาหนะที่ขับเคลื่อนด้วยตนเองให้เหมาะสมด้วย Cocoon LiDAR ของ LeddarTech

COAST Autonomous เลือกเทคโนโลยี LiDAR แบบโซลิดสเตทของ LeddarTech ซึ่งเป็นโซลูชั่นที่น่าเชื่อถือมากที่สุดเพื่อบรรลุระดับความปลอดภัยสูงสุดสำหรับยานพาหนะขับเคลื่อนด้วยตนเองที่ออกแบบมาสำหรับสภาพแวดล้อมแบบสถานศึกษาและชานเมือง

เมืองควิเบค, June 04, 2019 (GLOBE NEWSWIRE) — LeddarTech® ผู้นำในอุตสาหกรรมในด้านเทคโนโลยี LiDAR สำหรับยานยนต์และยานพาหนะ มีความยินดีที่จะประกาศว่า COAST Autonomous ได้เลือก LeddarTech สำหรับยานยนต์ที่ขับเคลื่อนด้วยตนเองของบริษัท COAST Autonomous ซึ่งก่อตั้งโดยผู้มีประสบการณ์ในอุตสาหกรรมยานยนต์ขับเคลื่อนด้วยตนเอง เลือกเทคโนโลยีของ LeddarTech เนื่องจากความสามารถในการมอบความปลอดภัยที่เพิ่มขึ้นสำหรับยานพาหนะของ COAST Autonomous ความทนทานและความน่าเชื่อถือของเทคโนโลยีแบบโซลิดสเตทของ LeddarTech ตอบสนองเงื่อนไขการเคลื่อนที่ที่เป็นที่ต้องการในปัจจุบัน และได้รับเลือกให้เป็นเทคโนโลยีป้องกันการชนในการใช้งานที่ไม่บ่อยนัก โดยกำจัดเขตอับสัญญาณเหลืออยู่ด้วยเทคโนโลยีการรับรู้อื่นๆ

COAST Autonomous ได้พัฒนายานพาหนะที่ขับเคลื่อนด้วยตนเองที่ผสมผสานเทคโนโลยีการตรวจจับหลายประเภท รวมถึง LiDAR, RADAR และกล้อง LiDAR ของ LeddarTech ได้ให้การครอบคลุมโดยสมบูรณ์ โดยไม่มีเขตอับสัญญาณโดยรอบยานพาหนะ ซึ่งเรียกว่า Cocoon สิ่งนี้จะป้องกันผู้ใช้รถใช้ถนนที่เป็นเปราะบาง เช่น คนเดินถนนที่อาจชนเข้ากับยานพาหนะในบางสถานการณ์  Cocoon LiDAR ของ LeddarTech มอบโซลูชั่นที่ไม่เหมือนใคร ซึ่งทำให้เป็นยานพาหนะที่ขับเคลื่อนด้วยตนเองเต็มรูปแบบที่ปลอดภัย “ด้วยความตั้งใจที่จะมอบการขับขี่ที่ปลอดภัยที่สุดของผู้โดยสาร การเลือกเทคโนโลยีการตรวจจับที่ของเรา จึงได้คำนึงถึงประสบการณ์ของหุ้นส่วนที่เราทำงานด้วย และความสามารถในการส่งมอบคำมั่นสัญญาอย่างต่อเนื่อง” Pierre Lefevre ประธานเจ้าหน้าที่ฝ่ายเทคโนโลยีของ COAST Autonomous กล่าว “LeddarTech เป็นหุ้นส่วนที่ยอดเยี่ยมของเราและได้แสดงให้เห็นอย่างต่อเนื่องว่าสามารถปฏิบัติงานได้เกินความคาดหวังของเรา ด้วยประสบการณ์ในการสร้างเซ็นเซอร์ของ LiDAR กว่าหนึ่งทศวรรษ”

“ถือเป็นเกียรติของเราที่โซลูชั่น Cocoon LiDAR ของเราได้รับเลือกและได้รับความไว้วางใจจาก COAST Autonomous ให้เป็นส่วนหนึ่งของยานพาหนะขับเคลื่อนด้วยตนเอง” Adrian Pierce รองประธานฝ่ายการพัฒนาการขายและธุรกิจทั่วโลกของ LeddarTech กล่าว เขากล่าวต่อว่า “COAST มีสถิติที่ยอดเยี่ยมมาก ด้วยการทดลองมากกว่า 60 ครั้งใน 7 ประเทศและมีประวัติที่น่าประทับใจในการขนส่งผู้โดยสารกว่า 120,000 คน ส่วนประกอบแรกของสัญญารับเหมาของ Coast คือความปลอดภัยต้องมาก่อนและการปรับใช้ Cocoon LiDAR ของ LeddarTech สนับสนุนสัญญารับเหมานั้นรวมถึงพันธสัญญาที่ Coast ให้ไว้กับลูกค้า ”คุณ Pierce สรุปว่า “การทำให้การใช้งานยานยนต์ปลอดภัยยิ่งขึ้นเป็นหัวใจสำคัญของ DNA ของเรา เทคโนโลยีของเราเสนอความสมดุลเหมาะสมระหว่างประสิทธิภาพและความคุ้มค่า และพร้อมให้ปรับใช้แล้ววันนี้”

เกี่ยวกับ COAST Autonomous

COAST Autonomous คือบริษัทซอฟต์แวร์และเทคโนโลยีที่มุ่งเน้นกับการมอบโซลูชั่น AV ที่มีความเร็วที่เหมาะสมสำหรับสภาพแวดล้อมแบบชานเมืองและสถานศึกษา ภารกิจของ COAST คือการสร้างชุมชนโดยเชื่อมโยงผู้คนด้วยโซลูชั่นยานยนต์ที่ให้ความสำคัญกับคนเดินถนน และคืนเมืองกลับสู่ผู้คน ที่ใจกลางของหนึ่งในการขัดจังหวะที่ลึกล้ำและรวดเร็วที่สุดที่ส่งผลกระทบต่อแวดวงการคมนาคมและการขนส่ง COAST ได้พัฒนาซอฟต์แวร์ยานพาหนะที่ขับเคลื่อนด้วยตนเอง (AV) เป็นจำนวนมากอย่างเต็มรูปแบบ ซึ่งรวมถึง การทำแผนที่และการปรับให้เข้ากับท้องถิ่น การออกแบบหุ่นยนต์และปัญญาประดิษฐ์ (AI) การจัดการยานพาหนะและระบบการควบคุมดูแล การร่วมมือกับผู้ผลิตที่ได้รับการพิสูจน์แล้ว ทำให้ COAST สามารถให้บริการยานพาหนะที่มาพร้อมกับซอฟต์แวร์ที่ดีที่สุดที่หลากหลาย เพื่อมอบโซลูชั่นระบบขนส่งเป็นการให้บริการ (MaaS) ไปยังเมือง สวนสนุก สถานศึกษา สนามบิน และสภาพแวดล้อมชานเมืองอื่นๆ ทีมของ COAST ซึ่งอยู่ที่พาซ่าเดน่า แคลิฟอร์เนีย ได้รับการยอมรับสำหรับประสบการณ์และความชำนาญในการปรับใช้และการดำเนินการทุกด้านกับฝูง AV พร้อมทั้งให้ความสำคัญกับความปลอดภัยและประสบการณ์ของผู้ใช้ในขณะเดียวกัน หากต้องการเรียนรู้ว่า COAST Autonomous ช่วยให้คุณมีพละกำลังในการขนส่งแบบขับเคลื่อนด้วยตนเองในสภาพแวดล้อมของคุณได้อย่างไร โปรดไปที่ www.coastautonomous.com

ติดต่อ: Aimie Nghiem ผู้อำนวยการพัฒนาโปรแกรม COAST Autonomous
โทร: +1-626-838-2469 ANghiem@coastautonomous.com

เกี่ยวกับ LeddarTech®

LeddarTech เป็นผู้นำด้านอุตสาหกรรมในการมอบแพลตฟอร์มการพัฒนา LiDAR สำหรับยานยนต์ที่มีความอเนกประสงค์และขยายขนาดได้มากที่สุดโดยใช้ LeddarEngineTM ที่เป็นเอกลักษณ์ ซึ่งประกอบด้วยชุดของระดับยานยนต์และ SoC ที่ได้รับการรับรองความปลอดภัยด้านการทำงาน ซึ่งทำงานควบคู่กับซอฟต์แวร์การประมวลผลสัญญาณ LeddarSP ที่มีกรรมสิทธิ์ บริษัทเป็นผู้รับผิดชอบในการคิดค้นนวัตกรรมใหม่ๆ ในแอปพลิเคชันตรวจจับระยะไกลที่ทันสมัยด้วยเทคโนโลยีที่มีสิทธิบัตรกว่า 70 รายการ (รอดำเนินการ 20 รายการ) ซึ่งเป็นการเพิ่มขีดความสามารถ ADAS และการขับขี่แบบอัตโนมัติสำหรับรถยนต์

LeddarTech ยังให้บริการตลาดยานพาหนะด้วยโซลูชั่นโมดูล LiDAR แบบโซลิดสเตทประสิทธิภาพสูงสำหรับรถรับส่งอัตโนมัติไร้คนขับ รถบรรทุก รถโดยสาร รถขนส่งและหุ่นยนต์รถแท็กซี่อีกด้วย

สามารถดูข้อมูลเพิ่มเติมเกี่ยวกับ LeddarTech ได้ที่ www.LeddarTech.com และบน LinkedInTwitterFacebook และ YouTube

ติดต่อ: Daniel Aitken รองประธานฝ่ายการตลาดและการสื่อสารของ LeddarTech
โทร: +1-418-653-9000 ต่อ 232 Daniel.Aitken@Leddartech.com

โลโก้ Leddar, LeddarTech และ LeddarTech เป็นเครื่องหมายการค้าหรือเครื่องหมายการค้าจดทะเบียนของ LeddarTech Inc. แบรนด์ ชื่อผลิตภัณฑ์และเครื่องหมายต่างๆ ทั้งหมด เป็นหรืออาจเป็นเครื่องหมายการค้าที่ใช้เพื่อระบุถึงผลิตภัณฑ์หรือบริการต่างๆ ของเจ้าของที่เกี่ยวข้อง

COAST Autonomous Optimizes Self Driving Vehicle Safety with LeddarTech’s Cocoon LiDAR

COAST Autonomous selects LeddarTech’s solid-state LiDAR technology as the most reliable solution to achieve maximum safety levels for its self-driving vehicles designed for campus and urban environments.

QUEBEC CITY, June 04, 2019 (GLOBE NEWSWIRE) — LeddarTech®, an industry leader in automotive and mobility LiDAR technology, is pleased to announce that COAST Autonomous has selected LeddarTech for its autonomous shuttles. COAST Autonomous, founded by veterans of the self-driving industry, chose LeddarTech’s technology because of its ability to deliver enhanced safety for COAST Autonomous’ vehicles. The robustness and reliability of LeddarTech’s solid-state technology meet today’s demanding mobility conditions and makes it the technology of choice toward preventing collisions in stop-and-go applications by eliminating dead zones left by other sensing technologies.

COAST Autonomous has developed self-driving vehicles that integrate several detection technologies, including LiDAR, RADAR, and camera. LeddarTech’s LiDAR provides full coverage with no dead zones within the entire perimeter of the vehicle, also referred to as the cocoon. This protects vulnerable road users such as pedestrians who may approach the vehicle in stop-and-go situations.  LeddarTech’s cocoon LiDAR provides a unique solution enabling safe, fully autonomous vehicles. “With the intent of providing the safest rides to our passengers, our selection of detection technologies takes into consideration the maturity of the partners we work with and their ability to consistently deliver on their promises,” stated Pierre Lefevre, Chief Technology Officer at COAST Autonomous. “With more than a decade of experience building LiDAR sensors, LeddarTech is the perfect partner for us and has consistently shown it could exceed our expectations.”

“We are honored that our cocoon LiDAR solutions were selected and trusted by COAST Autonomous to be part of its self-driving vehicles,” stated Adrian Pierce, VP of Global Sales & Business Development of LeddarTech. He went on to say, “COAST has an amazing track record with over 60 trials in 7 different countries and impressive history of transporting over 120,000 passengers. The first element of Coast’s charter is safety first, and the deployment of LeddarTech’s cocoon LiDAR supports that charter and the commitment Coast makes to their customers. ” Mr. Pierce concluded that “making mobility applications safer is at the core of our DNA. Our technology offers the right balance of performance and cost-effectiveness and is ready for deployment today.”

About COAST Autonomous

COAST Autonomous is a software and technology company focused on delivering AV solutions at appropriate speeds for urban and campus environments. COAST’s mission is to build community by connecting people with mobility solutions that put pedestrians first and give cities back to people. At the center of one of the fastest and most profound disruptions to impact the transportation and logistics industries, COAST has developed the full stack of Autonomous Vehicle (AV) software that includes mapping and localization, robotics and artificial intelligence (AI), fleet management and supervision systems. Partnering with proven manufacturers, COAST can provide a variety of vehicles equipped with its best-in-class software to offer Mobility-as-a-Service (MaaS) solutions to cities, theme parks, campuses, airports, and other urban environments. Based in Pasadena, California, COAST’s team is recognized for its experience and expertise in all aspects of implementing and operating AV fleets while prioritizing safety and the user experience. To learn how COAST Autonomous can help you power autonomous transportation in your environment, please visit www.coastautonomous.com.

Contact: Aimie Nghiem, Director of Program Development, COAST Autonomous
Tel: +1-626-838-2469 ANghiem@coastautonomous.com

About LeddarTech®

LeddarTech is an industry leader providing the most versatile and scalable automotive LiDAR development platform based on the unique LeddarEngineTM which consists of a suite of automotive-grade, functional safety certified SoCs working in tandem with proprietary LeddarSP signal processing software. The company is responsible for several innovations in cutting-edge mobility remote-sensing applications, with over 70 patented technologies (20 pending) enhancing ADAS and autonomous driving capabilities for automobiles.

LeddarTech also serves the mobility market with solid-state high-performance LiDAR module solutions for autonomous shuttles, trucks, buses, delivery vehicles and robotaxis.

Additional information about LeddarTech is accessible at www.LeddarTech.com, and on LinkedInTwitterFacebook, and YouTube.

Contact: Daniel Aitken, Vice President of Marketing and Communications, LeddarTech
Tel.: +1-418-653-9000 ext. 232 Daniel.Aitken@Leddartech.com

Leddar, LeddarTech, and LeddarTech logos are trademarks or registered trademarks of LeddarTech Inc. All other brands, product names, and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

Vietnam Steps Up Punishment of Journalists, Bloggers

WASHINGTON Carolyn Komatsoulis contributed to this report

Twenty-five members of Congress wrote to Secretary of State Mike Pompeo last week to urge greater freedom of expression in Vietnam, where the one-party communist state has aggressively jailed bloggers and activists.

The letter comes two months after the U.N. Human Rights Committee released a report criticizing the Vietnamese government for repression against activists and journalists and executing high numbers of people guilty of minor crimes after unfair trials.

The report and the letter describe pervasive state control over Vietnamese media, the conviction of Radio Free Asia (RFA) blogger and videographer Nguyen Van Hoa, Voice of America (VOA) contributor Le Anh Hung’s wait for a trial, and the abduction of an RFA contributor.

Vietnam is a signatory to the International Covenant on Civil and Political Rights (ICCPR) and as such has committed to respecting individual freedoms of belief, speech, association, press, and the right to uphold assembly and political expression, the lawmakers wrote in the letter.

The United States has an obligation to both raise these egregious human and political rights violations with its Vietnamese counterparts and take steps to shape the behavior of the Communist Party of Vietnam.

Officials at the Vietnamese Embassy in Washington, D.C. did not return multiple requests for comment.

The Vietnam Committee on Human Rights (VCHR), a civil society group in Paris, praised the findings of the report and said one-party control prevents progress on the human rights frontier.

Concretely, the U.N. experts recommend that Vietnam ensures political pluralism, holds transparent and genuine elections, promotes media freedom and respects the right to form independent trade unions and NGOs in order to fully implement the ICCPR, said VHCR President VA Van A�i.

He called on the Vietnamese government to abolish the constitutional article that gives monopoly control to the Communist Party, as its citizens insistently demanded during the Constitutional reform in 2013.

Vietnam has one of the world’s worst rankings in press freedom by the group Reporters Without Borders — 176th out of 180 nations.

Last year, a Vietnamese court sentenced a dissident writer and activist to 20 years in prison for trying to overthrow the government. The conviction came after a short trial in which witnesses who might have cleared him were prohibited from appearing.

As of May, Vietnam held an estimated 128 prisoners of conscience, according to an Amnesty International report. Vietnam increased the number of prisoners of conscience it holds, up from 97 last year, according to Amnesty International.

The U.N. report in March explored several areas of concern, including the need for independent bodies to observe, promote and protect human rights, more clear terminology in Hanoi’s counter-terrorism efforts, and a framework for non-discrimination.

The report also advocated the right of peaceful assembly, freedom of association and participation in public affairs.

After the report, VA Van A�i called for international pressure on Vietnam.

The international community should take heed of the U.N. experts’ conclusions and impress upon Vietnam that ‘business as usual’ cannot continue unless the Vietnamese government commits to substantive legislative and political reforms, he said.

In their letter, Sen. Edward Markey, D-Mass., and Rep. Alan Lowenthal, D-Calif., expressed concern about troubling cases of arrests and detentions of independent journalists.

Source: Voice of America